Your browser doesn't support javascript.
loading
Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B-cell lymphoma of the central nervous system - an international study of feasibility and efficacy in routine clinical practice.
Schorb, Elisabeth; Fox, Christopher P; Kasenda, Benjamin; Linton, Kim; Martinez-Calle, Nicolas; Calimeri, Teresa; Ninkovic, Slavisa; Eyre, Toby A; Cummin, Tom; Smith, Jeffery; Yallop, Deborah; De Marco, Beatrice; Krampera, Mauro; Trefz, Stefan; Orsucci, Lorella; Fabbri, Alberto; Illerhaus, Gerald; Cwynarski, Kate; Ferreri, Andrés J M.
Afiliação
  • Schorb E; Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Fox CP; Department of Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
  • Kasenda B; Department of Hematology, Oncology and Palliative Care, Klinikum Stuttgart, Stuttgart, Germany.
  • Linton K; Department of Medical Oncology & Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland.
  • Martinez-Calle N; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Calimeri T; Department of Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
  • Ninkovic S; Lymphoma Unit, Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Eyre TA; Department of Haematology, University College London Hospital, London, United Kingdom.
  • Cummin T; Department of Haematology, Churchill Hospital, Oxford, United Kingdom.
  • Smith J; Cancer Research UK, Cancer Sciences, University of Southampton, Southampton, United Kingdom.
  • Yallop D; Department of Clinical Haematology, Aintree University Hospital, Liverpool, United Kingdom.
  • De Marco B; Department of Haematological Medicine, King's College Hospital, London, United Kingdom.
  • Krampera M; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
  • Trefz S; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
  • Orsucci L; Department of Hematology, Oncology and Palliative Care, Klinikum Stuttgart, Stuttgart, Germany.
  • Fabbri A; San Giovanni Battista Hospital and University, Turin, Italy.
  • Illerhaus G; Department of Oncology, Division of Hematology, Azienda Ospedaliera Universitaria Senese, Siena, Italy.
  • Cwynarski K; Department of Hematology, Oncology and Palliative Care, Klinikum Stuttgart, Stuttgart, Germany.
  • Ferreri AJM; Department of Haematology, University College London Hospital, London, United Kingdom.
Br J Haematol ; 189(5): 879-887, 2020 06.
Article em En | MEDLINE | ID: mdl-31997308
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Difuso de Grandes Células B / Imunoterapia Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged80 Idioma: En Revista: Br J Haematol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Difuso de Grandes Células B / Imunoterapia Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged80 Idioma: En Revista: Br J Haematol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha